https://www.youtube.com/watch?v=1buE0NmGOkg
Obesity Treatments: Trend, Necessity Or Overreach? | Vikrant Shrotriya | India Today Conclave 2025
Vikrant Shrotriya, Corporate Vice President & Managing Director, Novo Nordisk India, in Conversation with Kalli Purie, discusses the company’s stance on obesity as a disease and insights from 25 years of research. He explains the complexity of weight homeostasis, the role of genetics, and how modern lifestyles contribute to obesity. Vikrant addresses concerns about Ozempic, its effects on muscle loss, and its potential to treat multiple health issues. He also discusses the stigma around weight loss medication and the future accessibility of such treatments in India. #obesityawareness #novonordiskindia #indiatodayconclave2025 #vikrantshrotriya #ozempic #weightloss #publichealth #obesitytreatment #healthcareinnovation #metabolichealth #indiatoday #obesityinindia
